The option to continue or initiate treatment with approved AD medications during the trial, including cholinesterase inhibitors and recently approved anti-amyloid monoclonal antibody treatments that may be available during trial execution, will allow for important information to be gathered on the safety of concurrent use of these medications with different mechanisms of action and provides flexibility in an evolving therapeutic landscape
Like all medications, they come with potential side effectsmost commonly nausea, vomiting, and gastrointestinal discomfort
But these clinical trial numbers underrepresent real-world experience
Lastly, the clinical expert felt that this semaglutide tablets can be prescribed by specialty and community-based clinics
These data come from Cosmos, a dataset created in collaboration with a community of Epic health systems representing more than 300 million patient records from 1,800 hospitals and more than 41,000 clinics from all 50 U.S